218 related articles for article (PubMed ID: 12147931)
1. Use of lipid-lowering drugs and blood pressure control in patients with arterial hypertension.
Borghi C; Dormi A; Veronesi M; Immordino V; Ambrosioni E
J Clin Hypertens (Greenwich); 2002; 4(4):277-85. PubMed ID: 12147931
[TBL] [Abstract][Full Text] [Related]
2. Statins and blood pressure regulation.
Borghi C; Veronesi M; Prandin MG; Dormi A; Ambrosioni E
Curr Hypertens Rep; 2001 Aug; 3(4):281-8. PubMed ID: 11470010
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?
Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ
Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324
[TBL] [Abstract][Full Text] [Related]
4. Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
Ruland S; Gorelick PB
Curr Atheroscler Rep; 2003 Jan; 5(1):38-43. PubMed ID: 12562541
[TBL] [Abstract][Full Text] [Related]
5. Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.
Sirenko Y; Radchenko G;
High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):85-93. PubMed ID: 28150140
[TBL] [Abstract][Full Text] [Related]
6. Patient at intermediate cardiovascular risk: statins, yes! - antihypertensive therapy, maybe.
Volpe M; Costanzi V
J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e130-e132. PubMed ID: 29538162
[No Abstract] [Full Text] [Related]
7. Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium.
Chłopicki S; Gryglewski RJ
Pharmacol Rep; 2005; 57 Suppl():86-96. PubMed ID: 16415489
[TBL] [Abstract][Full Text] [Related]
8. Difficulties in reaching therapeutic goals for hypertension and dysplipidaemia in patients with type 2 diabetes in general practice.
Knudsen ST; Mosbech TH; Hansen B; Kønig E; Johnsen PC; Kamper AL
Dan Med J; 2013 Dec; 60(12):A4740. PubMed ID: 24355449
[TBL] [Abstract][Full Text] [Related]
9. Statins in hypertension: are they a new class of antihypertensive agents?
Feldstein CA
Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164
[TBL] [Abstract][Full Text] [Related]
10. Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.
Drapala A; Sikora M; Ufnal M
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):250-8. PubMed ID: 25037529
[TBL] [Abstract][Full Text] [Related]
11. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia.
Borghi C; Urso R; Cicero AF
Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):115-120. PubMed ID: 27745933
[TBL] [Abstract][Full Text] [Related]
13. Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes.
Raebel MA; Dyer W; Nichols GA; Goodrich GK; Schmittdiel JA
Pharmacotherapy; 2017 Oct; 37(10):1204-1214. PubMed ID: 28752555
[TBL] [Abstract][Full Text] [Related]
14. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
15. The effect of statins on angiotensin II-induced hemodynamic changes in young, mildly hypercholesterolemic men.
Fleischmann EH; John S; Delles C; Schneider MP; Schmidt BM; Schmieder RE
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1120-6. PubMed ID: 15607618
[TBL] [Abstract][Full Text] [Related]
16. Interactions between hypercholesterolemia and hypertension: implications for therapy.
Borghi C
Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):489-96. PubMed ID: 12187312
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study.
Ruszkowski P; Masajtis-Zagajewska A; Nowicki M
J Renin Angiotensin Aldosterone Syst; 2019; 20(3):1470320319868890. PubMed ID: 31486700
[TBL] [Abstract][Full Text] [Related]
18. Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness.
Kreyenbuhl J; Dickerson FB; Medoff DR; Brown CH; Goldberg RW; Fang L; Wohlheiter K; Mittal LP; Dixon LB
J Nerv Ment Dis; 2006 Jun; 194(6):404-10. PubMed ID: 16772856
[TBL] [Abstract][Full Text] [Related]
19. Do statins lower blood pressure?
Mangat S; Agarwal S; Rosendorff C
J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):112-23. PubMed ID: 17562781
[TBL] [Abstract][Full Text] [Related]
20. A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.
Alla VM; Agrawal V; DeNazareth A; Mohiuddin S; Ravilla S; Rendell M
Drugs; 2013 Jul; 73(10):1025-54. PubMed ID: 23754124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
